Determination of residual stress and thermal history
- 格式:pdf
- 大小:735.55 KB
- 文档页数:11
中国药品标准DrugStandardsofChina2021,22(1) ·5 · 第一作者简介:赵雄,副研究员,研究方向:生物制品研发及质量控制。
Tel:010 67079598;E mail:zhaoxiong@chp org cn 通讯作者简介:郭中平,研究员,研究方向:生物制品。
Tel:010 67079561;E mail:guozhongping@chp org cn《中国药典》2020年版(三部)生物技术产品增修订概况赵雄,王晓娟,曹琰,郭中平(国家药典委员会,北京100061)摘要:生物技术产业的快速发展推动了生物技术产品国家标准的不断提升。
本文介绍了《中国药典》2020年版(三部)生物技术产品及相关通用技术要求的增修订概况,阐释了增修订的考量和特点,旨在为正确理解和执行生物技术产品国家标准提供参考。
关键词:生物技术产品;国家标准;增修订中图分类号:R921 2 文献标识码:A 文章编号:1009-3656(2021)01-0005-05doi:10 19778/j chp 2021 01 001UpdatesandAmendmentsofBiotechnologyProductsintheChinesePharmacopoeia2020(VolumeⅢ)ZHAOXiong,WANGXiaojuan,CAOYan,GUOZhongping(ChinesePharmacopoeiaCommission,Beijing100061,China)Abstract:Therapiddevelopmentofthebiotechnologyindustryhaspromotedthecontinuousimprovementofnation alstandardsforbiotechnologyproducts TheupdatesandamendmentsofbiotechnologyproductsandgeneralrequirementsintheChinesePharmacopoeia2020(VolumeⅢ)areintroduced,andtheconsiderationsandcharac teristicsoftherevisionsareexplained Thataimstoprovideareferencefortheaccurateunderstandingandimple mentationofnationalstandardsforbiotechnologyproducts.Keywords:biotechnologyproducts;nationalstandards;updatesandamendments 生物技术产品是指采用生物技术制备的、临床上用于疾病治疗的大分子生物制品[1]。
采用显微硬度压痕法测量微区残余应力陈超,潘春旭,傅强(武汉大学物理科学与技术学院,声光材料与器件教育部重点实验室,湖北武汉430072)摘 要:测量材料微区残余应力的大小和分布,对于研究微观断裂机制具有非常重要的意义,一直是研究的热点和难点。
尝试利用常规的维氏显微硬度压痕法研究和测量了材料中微米级微区的残余应力,推导出了残余应力与压痕面积比之间的理论公式,并选取低碳钢、紫铜和铝合金等三种具有不同性能的薄板材料,利用“三点弯曲”人为“原位”引入应力,通过试验测量对该方法进行了验证,并与原有的理论和方法进行了对比。
结果表明:该测量方法测量准确。
关键词:残余应力;显微硬度;压痕;弯曲中图分类号:TB302.5 文献标识码:A 文章编号:100023738(2007)0120008204Micro2residual Stress Measurement Using Vickers Micro2indentationCHEN Chao,PAN Chun2xu,FU Q iang(Wuhan University,Wuhan430072,China)Abstract:The measurement of the value and distribution for micro2residual stress in materials was crucial and difficult for micro2f racture theory.A regular Vickers micro2indentation for evaluating the micro2residual stress in micron2range was introduced.Three common metals including mild steel,copper and aluminum alloy were used in the experiment,and residual stresses were induced“in2situ”by using three2point bending.The results show that the present measurement is accurate.K ey w ords:residual stress;micro2hardness;indentation;bending0 引 言残余应力的传统测量技术一般分为具有一定损伤性的机械释放测量法和非破坏性无损伤的物理测量法[1],其中又以盲孔法和X射线衍射法较为成熟。
收稿日期:2001-07-12基金项目:国家自然科学基金资助项目(39930180)通讯作者:钟大放,Tel :(024)23902539。
文章编号:1006-2858(2002)02-0096-05液相色谱2质谱联用法测定牛奶中4种四环素类药物残留量贾 薇,孙 璐,史向国,陈笑艳,钟大放(沈阳药科大学药物代谢与药物动力学实验室,辽宁沈阳 110016)摘要:目的建立牛奶样品中四环素、土霉素、金霉素、美他环素药物残留量的测定方法,进一步探讨四环素类药物的电喷雾质谱规律。
方法生物样品经固相萃取后,采用Hypersil BDS 柱分离,以乙腈2水2甲酸(体积比3715∶6215∶112)作为流动相,采用电喷雾离子源,以正离子检测方式进行一级、二级质谱分析。
结果牛奶中四环素、土霉素及美他环素的检测限可达0105μg/mL ,金霉素的检测限可达011μg/mL 。
四环素、土霉素及美他环素的浓度在011~510μg/mL 内,金霉素浓度在012~1010μg/mL 内均呈线性。
结论该方法专属性强,灵敏度高,适用于牛奶或其他生物样品中四环素类药物测定。
关键词:四环素类;高效液相色谱2质谱法;固相萃取中图分类号:R 917 文献标识码:A 四环素类(TCs )为广谱抗菌药,常用于预防和治疗家禽疾病,如用于预防或治疗牛的乳腺炎和子宫炎等,还可用于维持肉食动物的健康并加速其生长。
但由于该类药物的不合理使用及滥用,可能存在动物性食品及牛奶中四环素类药物的残留问题。
美国、日本、欧共体等已规定牛奶中四环素类的最大残留量为011μg/mL [1]。
我国规定牛奶中土霉素的最大残留量为011mg/kg [2],对其他TCs 的最大残留量未做明确规定。
四环素类的分析方法有微生物法、生物发光法、荧光法、液相色谱2紫外法等[3],但这些方法有一些弱点,如专属性或灵敏度较差等。
近年来国外报道了液相色谱2质谱联用法测定生物样品中四环素(TC )、土霉素(O TC )及金霉素(CTC )含量[4],但样品前处理方法较繁琐,并且未见美他环素(M TC )测定方法的报道。
纳米压痕理论在残余应力检测方面的技术进展李青;刘士峰【摘要】This paper described the nano-indentation theory and two typical indentation models for characterizing the residual stress. The two models both assume that there is equal-biaxial residual stress on the specimen surface, and the model proposed by Suresh and A. E. Giannakopoulos can determine the residual stress through the contact area ratio of stressed and unstressed materials. Later, Y. H. Lee and D. Kwon modified the model, and transferred the contact area into the function of load. Therefore, the residual stress is only related to load. This paper also summarized the application examples which used the nano-indentation theory to detect residual stress. However, further research has to be made on the nano-indentation technique for detecting residual stress.%介绍了纳米压痕理论以及2种典型的测量残余应力的理论模型,这2种模型都假设表面存在等双轴残余应力.其中Suresh和A.E.Giannakopoulos模型测量残余应力是由存在残余应力时和没有残余应力时的接触面积之比来确定;随后Y.H.Lee和D.Kwon对该模型进行了修正,根据载荷与硬度的对应关系,将接触面积转换成载荷的函数;最后的残余应力计算仅与载荷有关.本文还详细综述了用纳米压痕理论检测残余应力的应用实例,最后提出用纳米压痕技术检测残余应力的可能性还有待更深入的研究.【期刊名称】《新技术新工艺》【年(卷),期】2013(000)003【总页数】3页(P118-120)【关键词】纳米压痕;理论模型;残余应力;检测【作者】李青;刘士峰【作者单位】军械工程学院,河北石家庄 050003;邢台轧辊小冷辊有限责任公司,河北邢台 054000【正文语种】中文【中图分类】TG174.44纳米压痕(nano indentation)技术又被称为深度敏感压痕(depth sensing indentation)技术,是近年发展起来的一种新技术,它可以在不分离薄膜与基底材料的情况下,直接得到薄膜材料的许多力学性质,如弹性模量、硬度、屈服强度、加工硬化指数等[1-3],其在微电子科学、表面喷涂、磁记录及薄膜等相关的材料科学领域得到越来越广泛的应用[4-6]。
USP38-通用章节指导目录(附录)Guide to General Chapters 通用章节指导General Requirements for Test and Assays检查与含量分析的一般要求<1>INJECTIONS AND IMPLANTED DRUG PRODUCTS (PARENTERALS)—PRODUCT QUALITY TESTS 注射和植入药物产品(注射用) —产品质量测试<1>INJECTIONS注射剂<2>ORAL DRUG PRODUCTS—PRODUCT QUALITY TESTS 口服药物产品质量测试<3>TOPICAL AND TRANSDERMAL DRUG PRODUCTS—PRODUCT QUALITY TESTS 局部和透皮药物产品—产品质量测试<4>MUCOSAL DRUG PRODUCTS—PRODUCT QUALITY TESTS 粘膜药物产品质量测试<5>INHALATION AND NASAL DRUG PRODUCTS—GENERAL INFORMATION AND PRODUCT QUALITY TESTS 吸入剂产品—产品质量测试<7>LABELING 标签<11>USP REFERENCE STANDARDS USP标准品Apparatus for Test and Assays用于检查与含量分析的器具<17>PRESCRIPTION CONTAINER LABELING处方容器标签<21>THERMOMETERS温度计<31>VOLUMETRIC APPARATUS容量器具<41>BALANCES天平Microbiological Tests 微生物检查法<51>ANTIMICROBIAL EFFECTIVENESS TESTING抗菌剂有效性检查法<55>BIOLOGICAL INDICATORS—RESISTANCE PERFORMANCE TESTS生物指示剂-耐药性实验<61>MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS: MICROBIAL ENUMERATION TESTS非无菌产品的微生物限度检查:微生物列举检查法<62>MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS: TESTS FOR SPECIFIED MICROORGANISMS 非无菌产品的微生物限度检查:特定微生物检查法<63>MYCOPLASMA TESTS 支原体检查法<71>STERILITY TESTS无菌检查法Biological tests and assays生物检查法与测定法<81>ANTIBIOTICS—MICROBIAL ASSAYS抗生素-微生物测定<85>BACTERIAL ENDOTOXINS TEST细菌内毒素检查法<87>BIOLOGICAL REACTIVITY TESTS, IN VITRO体外的生物反应性检查法<88>BIOLOGICAL REACTIVITY TESTS, IN VIVO 体内的生物反应性检查法<89>ENZYMES USED AS ANCILLARY MATERIALS IN PHARMACEUTICAL MANUFACTURING 药品生产中酶作为辅料所使用<90>FETAL BOVINE SERUM—QUALITY ATTRIBUTES AND FUNCTIONALITY TESTS 牛胎儿血清-质量品质和功能检查法<91>CALCIUM PANTOTHENATE ASSAY泛酸钙测定法<92>GROWTH FACTORS AND CYTOKINES USED IN CELL THERAPY MANUFACTURING 在细胞疗法中使用生长因子和细胞因子<111>DESIGN AND ANALYSIS OF BIOLOGICAL ASSAYS 生物测定法的设计与分析<115>DEXPANTHENOL ASSAY右泛醇(拟胆碱药)测定法<121>INSULIN ASSAYS胰岛素测定法<121.1>PHYSICOCHEMICAL ANALYTICAL PROCEDURES FOR INSULINS胰岛素的物理化学分析程序<123>GLUCAGON BIOIDENTITY TESTS 高血糖素的生物鉴别检查法<124>ERYTHROPOIETIN BIOASSAYS 红细胞生成素的微生物测定<126>SOMATROPIN BIOIDENTITY TESTS 生长激素的生物鉴别检查法<130>PROTEIN A QUALITY ATTRIBUTES 蛋白质A的质量特征<151>PYROGEN TEST热原检查法<161>TRANSFUSION AND INFUSION ASSEMBLIES AND SIMILAR MEDICAL DEVICES 输血输液用具以及相类似的医疗器械<171>VITAMIN B12 ACTIVITY ASSAY……2548维生素B12活性测定法Chemical Tests and assays化学实验检查与测定法鉴别检查<181>IDENTIFICATION—ORGANIC NITROGENOUS BASES鉴别-有机氮碱化合物<191>IDENTIFICATION TESTS—GENERAL鉴别实验-通用<193>IDENTIFICATION—TETRACYCLINES鉴别-四环素类<197>SPECTROPHOTOMETRIC IDENTIFICATION TESTS分光光度计鉴别实验<201>THIN-LAYER CHROMATOGRAPHIC IDENTIFICATION TEST薄层色谱鉴别实验Limit Tests 限度检查法<206>ALUMINUM铝<207>TEST FOR 1,6-ANHYDRO DERIV ATIVE FOR ENOXAPARIN SODIUM依诺肝素钠的酐类衍生物实验<208>ANTI-FACTOR Xa AND ANTI-FACTOR IIa ASSAYS FOR UNFRACTIONATED AND LOW MOLECULAR WEIGHT HEPARINS普通肝素和低分子肝素产品中抗体Xa和抗体IIa测定<209>LOW MOLECULAR WEIGHT HEPARIN MOLECULAR WEIGHT DETERMINATIONS 低分子肝素钠分子量测定<211>ARSENIC砷<221>CHLORIDE AND SULFATE氯和硫<223>DIMETHYLANILINE二甲基苯胺<226>4-EPIANHYDRO-TETRACYCLINE4-?-四环素<227>4-AMINOPHENOL IN ACETAMINOPHEN-CONTAINING DRUG PRODUCTS 对乙酰氨酚药物产品中氨基酚<228>ETHYLENE OXIDE AND DIOXANE 环氧乙烷和二氧六环<231>HEA VY METALS重金属(删除)<232>ELEMENTAL IMPURITIES—LIMITS 元素杂质-限度<233>ELEMENTAL IMPURITIES—PROCEDURES 元素杂质-规程<241>IRON铁<251>LEAD铅<261>MERCURY汞<267>POROSIMETRY BY MERCURY INTRUSION 水银孔隙仪<268>POROSITY BY NITROGEN ADSORPTION–DESORPTION 氮吸附-解吸测定孔隙率<271>READILY CARBONIZABLE SUBSTANCES TEST易碳化物检查法<281>RESIDUE ON IGNITION炽灼残渣<291>SELENIUM硒Other Tests and Assays 其它检查法与测定法<301>ACID-NEUTRALIZING CAPACITY酸中和容量<311>ALGINATES ASSAY藻酸盐测定法<341>ANTIMICROBIAL AGENTS—CONTENT 抗菌剂-含量<345>Assay for Citric Acid/Citrate and Phosphate 柠檬酸/柠檬酸盐和磷酸盐的测定<351>ASSAY FOR STEROIDS类固醇(甾类化合物)测定法<361> BARBITURATE ASSAY 巴比妥类药物测定法<371>COBALAMIN RADIOTRACER ASSAY钴铵素放射性跟踪剂测定法<381>ELASTOMERIC CLOSURES FOR INJECTIONS 注射剂的弹性密封件<391>EPINEPHRINE ASSAY肾上腺素测定法<401>FATS AND FIXED OILS脂肪与混合油<411>FOLIC ACID ASSAY叶酸测定法<413>IMPURITIES TESTING IN MEDICAL GASES 医用气体杂质检查<415>MEDICAL GASES ASSAY 医用气体含量检查<425>IODOMETRIC ASSAY—ANTIBIOTICS碘量检查法-抗生素<429>LIGHT DIFFRACTION MEASUREMENT OF PARTICLE SIZE粒径的光衍射测量法<431>METHOXY DETERMINATION甲氧基测定法<441>NIACIN OR NIACINAMIDE ASSAY 烟酰或烟酰胺测定法<451>NITRITE TITRATION亚硝酸盐滴定<461>NITROGEN DETERMINATION氮测定法<466>ORDINARY IMPURITIES一般杂质<467>RESIDUAL SOLVENTS残留溶剂<469>ETHYLENE GLYCOL, DIETHYLENE GLYCOL, AND TRIETHYLENE GLYCOL IN ETHOXYLATED SUBSTANCES乙氧基物质中乙二醇、二甘醇、三甘醇测定<471>OXYGEN FLASK COMBUSTION氧瓶燃烧法<481>RIBOFLAVIN ASSAY核黄素(维生素B2)测定法<501>SALTS OF ORGANIC NITROGENOUS BASES有机氮盐<503>ACETIC ACID IN PEPTIDES 多肽类中乙酸测定<511>SINGLE-STEROID ASSAY单一的类固醇测定法<525>SULFUR DIOXIDE 二氧化硫<531>THIAMINE ASSAY硫胺素测定法<541>TITRIMETRY滴定法<551>VITAMIN E ASSAY维生素E测定法<561>ARTICLES OF BOTANICAL ORIGIN植物起源的药品<563>IDENTIFICATION OF ARTICLES OF BOTANICAL ORIGIN植物药品的鉴别<565>BOTANICAL EXTRACTS植物提取<571>VITAMIN A ASSAY维生素A测定法<581>VITAMIN D ASSAY维生素D测定法<591>ZINC DETERMINATION锌的测定法Physical Test and Determinations物理检查与测定法<601>INHALATION AND NASAL DRUG PRODUCTS: AEROSOLS, SPRAYS, AND POWDERS—PERFORMANCE QUALITY TESTS吸入剂、鼻雾剂:气溶胶,喷雾,干粉-质量通则<602>PROPELLANTS 推进剂<603>TOPICAL AEROSOLS 局部喷雾剂<604>LEAK RATE 渗漏率<610>ALTERNATIVE MICROBIOLOGICAL SAMPLING METHODS FOR NONSTERILE INHALED AND NASAL PRODUCTS非无菌吸入和鼻雾剂可供选择的微生物取样方法<611>ALCOHOL DETERMINATION乙醇测定法<616>BULK DENSITY AND TAPPED DENSITY堆密度与振实密度<621>CHROMATOGRAPHY色谱法<631>COLOR AND ACHROMICITY呈色与消色<641>COMPLETENESS OF SOLUTION溶解度<643>TOTAL ORGANIC CARBON总有机碳<645>W ATER CONDUCTIVITY水电导率<651>CONGEALING TEMPERATURE凝点温度<659>PACKAGING AND STORAGE REQUIREMENTS 包装和储藏要求<660>CONTAINERS—GLASS 容器-玻璃<661>CONTAINERS—PLASTICS容器-塑料<670>AUXILIARY PACKAGING COMPONENTS 辅助包装部件<671>CONTAINERS—PERFORMANCE TESTING容器-性能测试<691>COTTON棉花<695>CRYSTALLINITY结晶度<696>CHARACTERIZATION OF CRYSTALLINE SOLIDS BY MICROCALORIMETRY AND SOLUTION CALORIMETRY 通过溶液量热学测定结晶性<697>CONTAINER CONTENT FOR INJECTIONS 注射剂容器容积<698>DELIVERABLE VOLUME抽取体积<699>DENSITY OF SOLIDS固体密度<701>DISINTEGRATION崩解时限<705>QUALITY ATTRIBUTES OF TABLETS LABELED AS HA VING A FUNCTIONAL SCORE ?<711>DISSOLUTION 溶出度<721>DISTILLING RANGE馏程<724>DRUG RELEASE药物释放度<729>GLOBULE SIZE DISTRIBUTION IN LIPID INJECTABLE EMULSIONS脂类可注射的乳剂的粒径分布<730>Plasma Spectrochemistry 血浆光谱化学?<731>LOSS ON DRYING4干燥失重<733>LOSS ON IGNITION灼烧失重<735>X-RAY FLUORESCENCE SPECTROMETRY X射线光谱<736>MASS SPECTROMETRY 质谱<741>MELTING RANGE OR TEMPERATURE熔距或熔点<751>METAL PARTICLES IN OPHTHALMIC OINTMENTS眼用软膏中的金属粒子<755>MINIMUM FILL最低装量<761>NUCLEAR MAGNETIC RESONANCE核磁共振<771>OPHTHALMIC OINTMENTS眼用软膏<776>OPTICAL MICROSCOPY光学显微镜<781>OPTICAL ROTATION旋光度<785>OSMOLALITY AND OSMOLARITY渗透压<786>PARTICLE SIZE DISTRIBUTION ESTIMATION BY ANALYTICAL SIEVING 筛分法估算粒径分布<787>SUBVISIBLE PARTICULATE MATTER IN THERAPEUTIC PROTEIN INJECTIONS显微计数法在治疗性蛋白注射剂中应用<788>PARTICULATE MATTER IN INJECTIONS注射剂中的不溶性微粒<789>PARTICULATE MATTER IN OPHTHALMIC SOLUTIONS眼用溶液中的不溶性微粒<790>VISIBLE PARTICULATES IN INJECTIONS 注射剂中可见异物<791>pH<795>PHARMACEUTICAL COMPOUNDING—NONSTERILE PREPARATIONS药物混合-非无菌制剂<797>PHARMACEUTICAL COMPOUNDING—STERILE PREPARATIONS药物混合-无菌制剂<801>POLAROGRAPHY极谱法<811>POWDER FINENESS粉剂细度<821>RADIOACTIVITY放射性<823>POSITRON EMISSION TOMOGRAPHY DRUGS FOR COMPOUNDING, INVESTIGATIONAL, AND RESEARCH USES用于正电子发射断层造影术的放射性药物<831>REFRACTIVE INDEX折光率<841>SPECIFIC GRAVITY比重<846>SPECIFIC SURFACE AREA 比表面积<851>SPECTROPHOTOMETRY AND LIGHT-SCATTERING分光光度计与光散射<852>ATOMIC ABSORPTION SPECTROSCOPY 原子吸收光谱<853>FLUORESCENCE SPECTROSCOPY 荧光光谱<854>MID-INFRARED SPECTROSCOPY 中红外光谱<857>ULTRAVIOLET-VISIBLE SPECTROSCOPY 紫外可见光谱<861>SUTURES—DIAMETER缝线-直径?<871>SUTURES—NEEDLE ATTACHMENT缝线-穿孔实验<881>TENSILE STRENGTH张力<891>THERMAL ANALYSIS热分析<905>UNIFORMITY OF DOSAGE UNITS制剂单位的含量均匀度<911>VISCOSITY—CAPILLARY METHODS黏度-毛细管法<912>VISCOSITY—ROTATIONAL METHODS 黏度-旋转法<913>VISCOSITY—ROLLING BALL METHOD 黏度-球法<921>W ATER DETERMINATION水分测定<941>CHARACTERIZATION OF CRYSTALLINE AND PARTIALLY CRYSTALLINE SOLIDS BY X-RAY POWDER DIFFRACTION (XRPD)X光衍射General Information通用信息<1005>ACOUSTIC EMISSION 声频发射<1010>ANALYTICAL DATA—INTERPRETATION AND TREATMENT分析数据-解释与处理<1015>AUTOMATED RADIOCHEMICAL SYNTHESIS APPARATUS放射性自动合成装置<1024>BOVINE SERUM 牛血清<1027>FLOW CYTOMETRY 流式细胞仪<1030>BIOLOGICAL ASSAY CHAPTERS—OVERVIEW AND GLOSSARY生物测定章节-综述和术语<1031>THE BIOCOMPATIBILITY OF MATERIALS USED IN DRUG CONTAINERS, MEDICAL DEVICES, AND IMPLANTS用于药物容器、医疗设施和植入剂的材料的生物相容性<1034>ANALYSIS OF BIOLOGICAL ASSAYS 生物测定分析<1035>BIOLOGICAL INDICATORS FOR STERILIZATION灭菌用生物指示剂<1041>BIOLOGICS生物制剂<1043>Ancillary Material for Cell, Gene, and Tissue-Engineered Products细胞,基因与组织设计产品的辅助材料<1044>CRYOPRESERV ATION OF CELLS 细胞低温保存<1045>BIOTECHNOLOGY-DERIVED ARTICLES生物技术提取产品<1046>CELLULAR AND TISSUE-BASED PRODUCTS细胞与组织产品<1047>GENE THERAPY PRODUCTS 基因治疗产品<1048>QUALITY OF BIOTECHNOLOGICAL PRODUCTS: ANALYSIS OF THE EXPRESSION CONSTRUCT IN CELLS USED FOR PRODUCTION OF r-DNA DERIVED PROTEIN PRODUCTS 生物技术产品的质量:从蛋白质产品中提取的r-DNA产品在细胞中表达结构的分析<1049>QUALITY OF BIOTECHNOLOGICAL PRODUCTS: STABILITY TESTING OF BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS生物技术产品的质量:生物技术/生物产品的稳定性实验<1050>VIRAL SAFETY EV ALUATION OF BIOTECHNOLOGY PRODUCTS DERIVED FROM CELL LINES OF HUMAN OR ANIMAL ORIGIN从人或动物细胞中提取的生物技术产品的病毒安全性评估<1051>CLEANING GLASS APPARATUS玻璃容器的清洗<1052>BIOTECHNOLOGY-DERIVED ARTICLES—AMINO ACID ANALYSIS生物技术提取法-氨基酸测定<1053>CAPILLARY ELECTROPHORESIS 毛细管电泳法<1054>BIOTECHNOLOGY-DERIVED ARTICLES—ISOELECTRIC FOCUSING生物技术提取法-等电点聚集<1055>BIOTECHNOLOGY-DERIVED ARTICLES—PEPTIDE MAPPING生物技术提取法-肽谱<1056>BIOTECHNOLOGY-DERIVED ARTICLES—POLYACRYLAMIDE GEL ELECTROPHORESIS 生物技术提取法-凝胶电泳<1057>BIOTECHNOLOGY-DERIVED ARTICLES—TOTAL PROTEIN ASSAY生物技术提取法-总蛋白测定<1058>ANALYTICAL INSTRUMENT QUALIFICATION 分析仪器要求<1059>EXCIPIENT PERFORMANCE 赋形剂<1061>COLOR—INSTRUMENTAL MEASUREMENT显色-仪器测量<1065>Ion Chromatography 离子色谱法<1066>PHYSICAL ENVIRONMENTS THAT PROMOTE SAFE MEDICATION USE物理环境促使安全使用药物<1072>DISINFECTANTS AND ANTISEPTICS 消毒剂和防腐剂<1074>EXCIPIENT BIOLOGICAL SAFETY EV ALUATION GUIDELINES赋形剂(辅料)生物安全性评估指导<1078>GOOD MANUFACTURING PRACTICES FOR BULK PHARMACEUTICAL EXCIPIENTS 批药品赋形剂的生产管理规范<1079>Good Storage and Shipping Practices 良好的贮存与运输规范<1080>BULK PHARMACEUTICAL EXCIPIENTS—CERTIFICATE OF ANALYSIS批药品赋形剂-COA<1084>GLYCOPROTEIN AND GLYCAN ANALYSIS—GENERAL CONSIDERATIONS 糖蛋白和多糖分析-一般通则<1086>IMPURITIES IN DRUG SUBSTANCES AND DRUG PRODUCTS药物和药物产品中的杂质<1087>APPARENT INTRINSIC DISSOLUTION—DISSOLUTION TESTING PROCEDURES FOR ROTATING DISK AND STATIONARY DISK内部的溶出度-旋转和静止溶出检测程序?<1088>IN VITRO AND IN VIVO EV ALUATION OF DOSAGE FORMS体内与体外的剂型的评估<1090>ASSESSMENT OF DRUG PRODUCT PERFORMANCE-BIOAV AILABILITY, BIOEQUIV ALENCE, AND DISSOLUTION药物产品性能评估:生物利用度、生物等效性和溶出<1091>LABELING OF INACTIVE INGREDIENTS非活性成分的标示<1092>THE DISSOLUTION PROCEDURE: DEVELOPMENT AND V ALIDATION溶出程序:开发与验证<1094>CAPSULES—DISSOLUTION TESTING AND RELATED QUALITY ATTRIBUTES 胶囊-关于产品质量的溶出测定<1097>BULK POWDER SAMPLING PROCEDURES:粉末样品取样程序<1102>IMMUNOLOGICAL TEST METHODS—GENERAL CONSIDERATIONS免疫测试方法-总则<1103>IMMUNOLOGICAL TEST METHODS—ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) 免疫学测试方法-酶联免疫吸附测定<1104>IMMUNOLOGICAL TEST METHODS—IMMUNOBLOT ANALYSIS免疫测试方法-免疫印迹法<1105>IMMUNOLOGICAL TEST METHODS—SURFACE PLASMON RESONANCE 免疫测试方法-表面等离子体共振<1106>IMMUNOGENICITY ASSAYS—DESIGN AND VALIDATION OF IMMUNOASSAYS TO DETECT ANTI-DRUG ANTIBODIES?<1111>MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS: ACCEPTANCE CRITERIA FOR PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR PHARMACEUTICAL USE非无菌产品的微生物学检查:药用制剂和制药过程使用的物质接受标准<1112>MICROBIAL CHARACTERIZATION, IDENTIFICATION, AND STRAIN TYPING 非无菌药物产品水活性测定应用<1113>MICROBIOLOGICAL ATTRIBUTES OF NONSTERILE PHARMACEUTICAL PRODUCTS 非无菌药品中的微生物分布<1115>BIOBURDEN CONTROL OF NONSTERILE DRUG SUBSTANCES AND PRODUCTS 非无菌药物和产品的生物负载控制<1116>MICROBIOLOGICAL CONTROL AND MONITORING OF ASEPTIC PROCESSING ENVIRONMENTS洁净的房间与其它可控环境的微生物评估<1117>MICROBIOLOGICAL BEST LABORATORY PRACTICES 微生物最优实验室规范<1118>MONITORING DEVICES—TIME, TEMPERATURE, AND HUMIDITY监控装置-时间、温度与湿度<1119>NEAR-INFRARED SPECTROPHOTOMETRY近红外分光光度测定法<1120>Raman Spectrophotometry 拉曼分光光度测定法<1121>NOMENCLATURE命名<1125>NUCLEIC ACID-BASED TECHNIQUES—GENERAL 核酸技术-通则<1126>NUCLEIC ACID-BASED TECHNIQUES—EXTRACTION, DETECTION, AND SEQUENCING 核酸技术-提取、检测、测序<1127>NUCLEIC ACID-BASED TECHNIQUES—AMPLIFICATION 核酸技术-扩增<1128>NUCLEIC ACID-BASED TECHNIQUES—MICROARRAY 核酸技术-微阵列<1129>NUCLEIC ACID-BASED TECHNIQUES—GENOTYPING 核酸技术-基因分型<1130>NUCLEIC ACID-BASED TECHNIQUES—APPROACHES FOR DETECTING TRACE NUCLEIC ACIDS (RESIDUAL DNA TESTING)核酸技术-探测微量核酸的应用(残留DNA测试)<1136>PACKAGING AND REPACKAGING—SINGLE-UNIT CONTAINERS包装和再包装-单一容器<1151>PHARMACEUTICAL DOSAGE FORMS药物剂型<1152>ANIMAL DRUGS FOR USE IN ANIMAL FEEDS兽药在动物饲料中的使用<1160>PHARMACEUTICAL CALCULATIONS IN PRESCRIPTION COMPOUNDING 按处方混合的药物的计算<1163>QUALITY ASSURANCE IN PHARMACEUTICAL COMPOUNDING按处方混合的药物的质量保证<1171>PHASE-SOLUBILITY ANALYSIS相溶解分析<1174>Powder Flow 粉末流动性<1176>PRESCRIPTION BALANCES AND VOLUMETRIC APPARATUS 处方天平与容量器具<1177>Good Packaging Practices 良好的包装操作<1178>Good Repackaging Practices 良好的再包装操作<1180>HUMAN PLASMA 人血浆<1181>SCANNING ELECTRON MICROSCOPY扫描电子显微镜<1184>SENSITIZATION TESTING 致敏测试<1191>STABILITY CONSIDERATIONS IN DISPENSING PRACTICE分装操作中稳定性考察<1195>SIGNIFICANT CHANGE GUIDE FOR BULK PHARMACEUTICAL EXCIPIENTS 散装药用辅料更换指导原则<1197>GOOD DISTRIBUTION PRACTICES FOR BULK PHARMACEUTICAL EXCIPIENTS 散装药用辅料良好的分装操作<1207>STERILE PRODUCT PACKAGING—INTEGRITY EV ALUATION无菌产品包装-完整性评估<1208>STERILITY TESTING—V ALIDATION OF ISOLATOR SYSTEMS无菌实验-隔离系统的验证<1209>STERILIZATION—CHEMICAL AND PHYSICOCHEMICAL INDICATORS AND INTEGRATORS灭菌-化学与物理化学的指示剂以及二者的综合<1211>STERILIZATION AND STERILITY ASSURANCE OF COMPENDIAL ARTICLES 药典物品中的灭菌与灭菌保证<1216>TABLET FRIABILITY片剂的脆碎度<1217>TABLET BREAKING FORCE 片剂断裂力<1222>TERMINALLY STERILIZED PHARMACEUTICAL PRODUCTS—PARAMETRIC RELEASE 药品终端灭菌-放行参数<1223>V ALIDATION OF ALTERNATIVE MICROBIOLOGICAL METHODS可供选择的微生物学方法的验证<1224>TRANSFER OF ANALYTICAL PROCEDURES 分析方法转移<1225>V ALIDATION OF COMPENDIAL PROCEDURES药典方法的验证<1226>VERIFICATION OF COMPENDIAL PROCEDURES 药典方法的确认<1227>V ALIDATION OF MICROBIAL RECOVERY FROM PHARMACOPEIAL ARTICLES从药物中回收微生物的验证<1229>STERILIZATION OF COMPENDIAL ARTICLES 药典灭菌过程<1229.1>STEAM STERILIZATION BY DIRECT CONTACT 直接蒸汽灭菌<1229.2>MOIST HEAT STERILIZATION OF AQUEOUS LIQUIDS 水溶液的湿热灭菌<1229.3>MONITORING OF BIOBURDEN 生物负载监控<1229.4>STERILIZING FILTRATION OF LIQUIDS 溶液的无菌过滤器<1229.6>LIQUID-PHASE STERILIZATION 液态灭菌<1229.7>GASEOUS STERILIZATION 气态灭菌<1229.8>DRY HEAT STERILIZATION 干热灭菌<1229.10>RADIATION STERILIZATION 辐射灭菌<1230>W ATER FOR HEMODIALYSIS APPLICATIONS 血液透析过程用水<1231>W ATER FOR PHARMACEUTICAL PURPOSES制药用水<1234>VACCINES FOR HUMAN USE—POLYSACCHARIDE AND GLYCOCONJUGATE VACCINES 人用疫苗-多糖和糖复合物疫苗<1235>V ACCINES FOR HUMAN USE—GENERAL CONSIDERATIONS 人用疫苗-通则<1237>VIROLOGY TEST METHODS 病毒测试方法<1238>V ACCINES FOR HUMAN USE—BACTERIAL V ACCINES 人用疫苗-细菌疫苗<1240>VIRUS TESTING OF HUMAN PLASMA FOR FURTHER MANUFACTURE下一步使用人血浆的病毒测试<1241>W ATER–SOLID INTERACTIONS IN PHARMACEUTICAL SYSTEMS在药物系统中水与固体的相互作用<1251>WEIGHING ON AN ANALYTICAL BALANCE关于分析天平的称重<1265>Written Prescription Drug Information-Guidelines 书面的处方药信息-指南<1285>PREPARATION OF BIOLOGICAL SPECIMENS FOR HISTOLOGIC AND IMMUNOHISTOCHEMICAL ANALYSIS为了组织和免疫组织分析的生物标本制备<1285.1>HEMATOXYLIN AND EOSIN STAINING OF SECTIONED TISSUE FOR MICROSCOPIC EXAMINATION显微镜观察用苏木精和伊红染色的切片<1601>PRODUCTS FOR NEBULIZATION—CHARACTERIZATION TESTS 产品雾化状态-性状描述<1644>THEORY AND PRACTICE OF ELECTRICAL CONDUCTIVITY MEASUREMENTS OF SOLUTIONS溶液电导值测量方法的理论与实践<1660>EV ALUATION OF THE INNER SURFACE DURABILITY OF GLASS CONTAINERS 玻璃容器内表面耐久性评估<1724>SEMISOLID DRUG PRODUCTS—PERFORMANCE TESTS 半固态药物产品-性能测试<1736>APPLICATIONS OF MASS SPECTROMETRY 质谱应用<1761>APPLICATIONS OF NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY核磁共振光谱应用<1787>MEASUREMENT OF SUBVISIBLE PARTICULATE MATTER IN THERAPEUTIC PROTEIN INJECTIONS用显微镜测量方法测量治疗性蛋白注射剂的不溶性微粒<1788>METHODS FOR THE DETERMINATION OF PARTICULATE MATTER IN INJECTIONS AND OPHTHALMIC SOLUTIONS注射剂和眼用溶液的不溶性微粒测定的方法选择<1852>ATOMIC ABSORPTION SPECTROSCOPY—THEORY AND PRACTICE原子吸收光谱-理论与实践<1853>FLUORESCENCE SPECTROSCOPY—THEORY AND PRACTICE荧光光谱-理论与实践<1854>MID-INFRARED SPECTROSCOPY—THEORY AND PRACTICE中红外光谱-理论与实践<1857>ULTRA VIOLET-VISIBLE SPECTROSCOPY—THEORY AND PRACTICE紫外可见光谱-理论与实践<1911>RHEOMETRY 流变测定Dietary Supplements营养补充剂General Tests and Assays 一般检查法与测定法<2021>MICROBIAL ENUMERATION TESTS—NUTRITIONAL AND DIETARY SUPPLEMENTS…3080微生物数量实验-营养与食品添加剂<2022>MICROBIOLOGICAL PROCEDURES FOR ABSENCE OF SPECIFIED MICROORGANISMS—NUTRITIONAL AND DIETARY SUPPLEMENTS (3083)不得检出特定微生物的程序-营养与营养补充剂<2023>MICROBIOLOGICAL ATTRIBUTES OF NONSTERILE NUTRITIONAL AND DIETARY SUPPLEMENTS……3087非无菌的营养与食品添加剂中的微生物分布<2040>DISINTEGRATION AND DISSOLUTION OF DIETARY SUPPLEMENTS (3089)食品添加剂的崩解与溶出<2091>WEIGHT V ARIATION OF DIETARY SUPPLEMENTS……3092食品添加剂的重量差异<2750>MANUFACTURING PRACTICES FOR DIETARY SUPPLEMENTS (3093)食品添加剂的生产操作。
学报Journal of China Pharmaceutical University2022,53(3):293-299293气相色谱法测定药用辅料聚西托醇1000中的残留杂质李浩宇1,2,唐宝强1,2,何东升1,2*,涂家生1,2**(1中国药科大学药学院药用辅料及仿创药物研发评价中心,南京210009;2国家药品监督管理局药物制剂及辅料研究与评价重点实验室,南京210009)摘要建立气相色谱法测定聚西托醇1000中残留的环氧乙烷、1,4-二氧六环、乙二醇、二甘醇和三甘醇等杂质,为聚西托醇1000生产质量控制提供参考。
采用DB-1色谱柱检测环氧乙烷和1,4-二氧六环,顶空进样,进样口温度150℃,检测器温度250℃,顶空平衡温度70℃,平衡时间45min。
采用VF-17MS色谱柱检测乙二醇、二甘醇和三甘醇,液体进样,进样口温度270℃,检测器温度290℃。
实验结果显示,环氧乙烷和1,4-二氧六环在各加样量范围内线性良好(r>0.999),精密度RSD小于8.0%,平均回收率分别为90.6%和101.2%;乙二醇、二甘醇和三甘醇在3~60μg/mL内线性关系良好(r> 0.999),精密度RSD小于3.0%,回收率均在96%~103%。
本研究所建立的方法具有良好的专属性、线性、精密度和回收率,能够有效检测聚西托醇1000中多组分极微量杂质。
关键词聚西托醇1000;杂质;气相色谱法;环氧乙烷;1,4-二氧六环;乙二醇;二甘醇;三甘醇中图分类号R944;R917文献标志码A文章编号1000-5048(2022)03-0293-07doi:10.11665/j.issn.1000-5048.20220306引用本文李浩宇,唐宝强,何东升,等.气相色谱法测定药用辅料聚西托醇1000中的残留杂质[J].中国药科大学学报,2022,53(3):293–299.Cite this article as:LI Haoyu,TANG Baoqiang,HE Dongsheng,et al.Determination of residual impurities in pharmaceutical excipient ceto⁃macrogol1000by gas chromatography[J].J China Pharm Univ,2022,53(3):293–299.Determination of residual impurities in pharmaceutical excipient cetomacro⁃gol1000by gas chromatographyLI Haoyu1,2,TANG Baoqiang1,2,HE Dongsheng1,2*,TU Jiasheng1,2**1Center for Research Development and Evaluation of Pharmaceutical Excipients and Generic Drugs,School of Pharmacy,China Pharmaceutical University,Nanjing210009;2National Medical Products Administration(NMPA)Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients,Nanjing210009,ChinaAbstract For the quality control of cetomacrogol1000,a gas chromatographic method for the determination of residual impurities in cetomacrogol1000,such as ethylene oxide,1,4-dioxane,ethylene glycol,diethylene glycol and triethylene glycol,was established and validated.The DB-1column with headspace injection was used to detect ethylene oxide and1,4-dioxane with the inlet temperature of150°C,the FID temperature of250°C,the headspace equilibration temperature of70°C and the equilibration time of45min.The VF-17MS column with liquid injection was used to detect ethylene glycol,diethylene glycol and triethylene glycol with the inlet tempera⁃ture of270°C,and the FID temperature of290°C.The results showed that ethylene oxide and1,4-dioxane havea good linearity within their specified addition amount ranges(r>0.999),with the RSD of precision of below8.0%and the average recovery rates of90.6%and101.2%;and that ethylene glycol,diethylene glycol and triethylene glycol also have a good linearity between3‒60μg/mL(r>0.999),with the RSD of precision of below3.0%,and the recovery rates of96%~103%.The method established in this study has good specificity,收稿日期2022-01-06通信作者*Tel:025-********E-mail:dongshenghe@**Tel:025-********E-mail:jiashengtu@基金项目国家“重大新药创制”科技重大专项资助项目(No.2017ZX09101001-006-002);国家药典委员会药品标准制修订研究课题2020Y047学报Journal of China Pharmaceutical University2022,53(3):293-299第53卷linearity,precision and recovery rate,which can effectively detect the multi-component and trace impurities. Key words cetomacrogol1000;impurity;gas chromatography;ethylene oxide;1,4-dioxane;ethylene glycol;diethylene glycol;triethylene glycolThis study was supported by China National Key Hi-Tech Innovation Project for the R&D of Novel Drugs(No.2017ZX09101001-006-002)and the Drug Standard Establishment and Revision Project of Chinese Pharmacopoeia Commission(No.2020Y047)聚西托醇1000(又称聚乙二醇十六烷基醚),是一种常见的药用辅料,化学式为C m H2m+1(OCH2CH2)n OH(m=16,n~20),本品由十六醇与一定数量的环氧乙烷通过缩合反应制得,产品中聚乙二醇的重复单元在2~20之间,当n=20时即为聚西托醇1000(商品名Brij-58)[1]。
船用钢Q345D中温塑性成形本构方程建立及分析张继祥;蒋飞;杨泮;唐博【摘要】采用SANS-CMT万能材料试验机,在温度为473~973 K和变形速率为0.001~0.1 s-1范围内对Q345D钢板试样进行拉伸实验,并对应力应变实验数据进行分析.结果表明:温度对Q345D钢中温塑性成形影响较大,而应变速率对成形影响较小.随着温度的升高,材料屈服强度σs和抗拉强度σb出现直线下降,较低温度下,拉伸应力应变曲线出现明显的屈服平台:塑性变形过程中存在着明显的加工硬化现象,加工硬化指数n随温度的上升而下降;延伸率δ随温度的升高近似线性增长;应变速率敏感系数m随温度的升高线性下降.%With a SANS-CMT universal material testing machine,the tensile test of Q345D steel plate specimen was carried out in the temperature ranging from 473 K to 973 K and the strain rate ranging from 0.001 s-1 to 0.1 s-1,and the stress-strain test data were analyzed.The results show that the temperature has a greater influence on the medium temperature plastic forming of Q345D steel,but the strain rate has less effect on the forming.The material yield strength σs and tensile strength σb decrease linearly with the increase of temperature,and the obvious yield platform appears in the tensile stress-strain curve at lower temperature.The hardening phenomena of Q345D steel are obvious in the process of plastic deformation,and the hardening exponent n decreases with the increase of temperature.With the temperature incre asing,the elongation rate δ increases linearly but the strain rate sensitivity coefficient m decreases linearly.【期刊名称】《重庆交通大学学报(自然科学版)》【年(卷),期】2018(037)003【总页数】6页(P121-126)【关键词】船舶工程;Q345D钢;中温塑性变形;本构方程【作者】张继祥;蒋飞;杨泮;唐博【作者单位】重庆交通大学机电与车辆工程学院,重庆400074;重庆交通大学机电与车辆工程学院,重庆400074;重庆交通大学机电与车辆工程学院,重庆400074;重庆交通大学机电与车辆工程学院,重庆400074【正文语种】中文【中图分类】U66.8.2;TG161船用Q345D钢具有强度和韧性高、抗冲击、耐腐蚀等优良特性[1],广泛用于桥梁、船舶、容器、建筑、车辆等。
Determination of residual stress and thermal historyfor IM7/977-2composite laminatesWilliam A.Schulz 1,Donald G.Myers,Tom N.Singer,Peter G.Ifju *,Raphael T.HaftkaDepartment of Mechanical and Aerospace Engineering,University of Florida,Gainesville,FL 32611,USAReceived 14September 2004;received in revised form 5April 2005;accepted 14April 2005Available online 13June 2005AbstractAs graphite/epoxy composites become more popular in advanced structural design,there is a need to better understand their mechanical behavior in extreme temperature posites offer many advantages over traditionally used materials;however,they tend to be susceptible to residual stress-induced failure.Residual strains,residual stresses,and thermal history of a composite panel are determined over a broad temperature range by using a combination of strain gages and an optical technique called the Cure Reference Method (CRM).CRM is an accurate,full field,method used to determine the strain on the surface of acomposite via Moire´Interferometry.CRM also enables the accurate determination of the chemical shrinkage of the epoxy matrix during cure.Classical Laminate Theory (CLT)is widely used to predict stress and strain in composite panels,yet it does not account for the chemical shrinkage of the epoxy.The paper describes a method to characterize multidirectional laminate behavior based on a few tests carried out on a unidirectional laminate.The purpose is to eliminate testing of each desired lay-up,by modifying CLT to predict the behavior of a multidirectional laminate based solely on the behavior of a unidirectional sample of the same material system.Testing various lay-ups and comparing analytical to experimental results is used to validate the model.Ó2005Elsevier Ltd.All rights reserved.Keywords:A.Polymer–matrix composites;B.Thermal properties;C.Residual stress;minate theory;D.Moire techniques1.IntroductionFor the next generation reusable launch vehicle to be viable,it is necessary to minimize airframe weight in or-der to increase the ability to carry more fuel.By reduc-ing the weight of the fuel tank as well as using it as a structural member,the relative percentage of fuel weight can be increased.In order to accomplish this goal,ad-vanced composite technology must be utilized.How-ever,the operating environment of the liquid hydrogen (LH 2)fuel tanks presents a serious challenge for theapplication of laminated composite materials.In order to safely utilize laminated composites in the cryogenic environment,there is a need to fully understand and measure the mechanisms that cause thermal stresses.Thermal stresses arise because of the mismatch in coefficient of thermal expansion (CTE)between the fi-bers and the epoxy matrix in laminates.These stresses can be quite large (up to or exceeding the failure strength of the matrix).In testing of the X-33LH 2fuel tanks [1],failure occurred as a result of thermal stress-induced micro-cracks,which led to hydrogen leakage through the face sheet and into the sandwich core.Dur-ing the transition back to room temperature,the hydro-gen trapped in the core expanded,and catastrophic delamination of the face sheets occurred.Chemical shrinkage of the epoxy during cure can also induce significant stresses in laminated composites [2,3],0266-3538/$-see front matter Ó2005Elsevier Ltd.All rights reserved.doi:10.1016/pscitech.2005.04.017*Corresponding author.Tel.:+13523926744;fax:+13523927303.E-mail addresses:wytshark@ufl.edu (W.A.Schulz),pgi@mae.ufl.edu (P.G.Ifju).1Tel.:+13525142376;fax:+1352392posites Science and Technology 65(2005)2014–2024/locate/compscitechCOMPOSITES SCIENCE AND TECHNOLOGYas much as15%of the thermal stresses.Chemical shrinkage is a permanent one-time phenomenon,in ther-moset polymers,that occurs during the initial cure pro-cess.The‘‘shrinkage’’is induced by the polymerization of the epoxy matrix during the cure cycle.The chemical shrinkage contribution is often neglected in analysis,as it is currently not an easy quantity to obtain.For the same reason,this contribution is rarely considered in experimental work on polymer matrix composites. Neglecting the chemical shrinkage contribution can lead to a less than accurate interpretation of the true physical behavior of the composite specimen.It is commonly as-sumed that at the cure temperature the composite is in a stress free state.While it is true that returning a speci-men to its cure temperature will remove the thermal stresses,the chemical shrinkage contribution remains. Through our experiments,it has been shown that the chemical shrinkage can be as high as0.2%strain,which is a significant quantity,and consequently should not be neglected.Taken together,thermal stress and chemical shrink-age comprise the residual stress in a composite.On the ply-scale it is possible to minimize the residual stresses by varying the ply angles.For instance,a uni-directional laminate has no residual stresses on the ply-scale,whereas a cross-ply represents the extreme case.A unidirectional composite,however,is a poor choice for carrying non-axial mechanical loads.There-fore,there is a tradeoffbetween load carrying strength and thermal strength,the latter referring to the ability for a material to avoid micro-cracking at low temper-atures.Trying to obtain the best orientation of plies for a specific task lends itself to a necessity for optimi-zation studies.The results obtained from this research are intended to be used as inputs in optimization studies.This paper describes the use of the Cure Reference Method(CRM)[4,5],combined with the coupling of Moire´Interferometry[6]and conventional strain gage measurements to characterize the thermal history and expansion as a function of temperature for a given com-posite material system.These thermal properties,as well as measured elastic properties,will be used as inputs for a Classical Laminate Theory(CLT)analysis,which is a commonly used analytical tool for predicting strains and stresses in composite laminates.A comparison will then be shown between the analytical prediction and our experimental results.Nomenclaturex–y coordinate system aligned with laminate0°(x)and90°(y)directions1–2coordinate system aligned with laminafiber(1)and transverse(2)directionsA1st quadrant of laminate stiffness matrix,3·3 CTE x coefficient of thermal expansion in the x-directionCTE y coefficient of thermal expansion in the y-directionE1lamina elastic modulus infiber directionE2lamina elastic modulus in transverse direction G12lamina shear modulusN x number of fringes in x-directionN y number of fringes in y-directionN applied force per unit length vector,3·1N M mechanical force per unit length vector,3·1 N T thermal force per unit length vector,3·1N C chemical force per unit length vector,3·1 NL number of layers in laminateQ ply stiffness matrixR reuter transformation matrix between engi-neering and tensorial strains,3·3T temperatureT test specific temperature of test/predictionT cure peak temperature of composite cure cycleD T temperature difference of(T testÀT cure)U horizontal displacementV vertical displacementa experimentally measured CTEa ave average laminate CTEc cos he x strain in the x-directione y strain in the y-directione chem chemical shrinkage vector of a unidirectionalpanel,3·1e lam laminate strain vector in x–y system,3·1 e res laminate residual strain vector in1–2system,3·1e uni strain vector on a unidirectional panel in thex–y system,3·1e CLT Classical Laminate Theory predicted strain e0laminate strain vector in x–y system mea-sured at midplane,3·1f frequency of reference diffraction gratingk ply indexs transformation matrix,3·3h angle between x–y and1–2coordinate systems r res residual stress vector in the1–2coordinate system,3·1s sin ht ply thicknessm12lamina PoissonÕs ratioW.A.Schulz et al./Composites Science and Technology65(2005)2014–202420152.Experimental purposeDue to the increase in desire to use composites,there are many methods to predict,characterize,and measure residual stress and strains in laminated composites. These methods consist of both computational and experimental techniques.Many experimental techniques are destructive[7–9]in nature and once a specimen has been tested it is no longer viable for use or further eval-uation,which is highly undesirable.For this reason, many non-destructive techniques have been developed and implemented.These include sensor-embedding [10,11],X-ray diffraction[12],and the Cure Reference Method[5].The goal of this research was to accurately determine the residual stress and thermal expansion coefficients as functions of temperature in a non-destructive manner via CRM and conventional strain gage technology. These thermal properties and behaviors are then to be used to improve optimization studies.A secondary goal was to improve the predictions generated with Classical Lamination Theory(CLT).This technique is used to predict stresses,strains,and curvatures for arbitrary stacking sequences,while the laminates experience mechanical,moisture,and thermal loads.Several samples of each of three prepreg laminates of the IM7/977-2material system shown in Fig.1were produced for analysis:(a)13layer unidirectional lay-up[013];(b)‘‘Quasi-isotropic’’lay-up½45=903=À45= O3s ;(c)optimized angle ply,[(±25)]3s.The‘‘quasi-isotropic’’lay-up is taken from the design of the LH2tank used in the NASA X-33project.We note that the lay-up is not a true quasi-isotropic lami-nate as the number of plies is not equivalent in all direc-tions,however,it will be referred to as such.The lay-up of the optimized angle ply sample stems from a reliabil-ity optimization performed by Qu et al.[13],of a LH2 fuel tank constructed from a graphite–epoxy system. The stacking sequence for the tank was[±h/±h]s.Opti-mal designs had ply angles h and h which were near+25°andÀ25°,and nearly equal;the stacking sequence was thus simplified to[±h]s.It should be noted that this opti-mized ply sequence was developed for a different mate-rial system,but it was used as a starting point to accrue statistical data on typical lay-ups.Variability is also an extremely important quantity to obtain.Our current research aims at being able to re-duce weight by reducing the variability of input proper-ties into reliability-based optimization studies.Current deterministic design practices employ safety factors in order to ensure reliability.This method,although effec-tive,results in the addition of extra material and conse-quently weight.Probabilistic designs,which are based on probability of failure,allow you to set target func-tions,such as minimizing the weight.The previous LH2tank optimization study showed that the skin thick-ness was highly affected by the variability in certain in-put material properties.Fig.2shows the importance of variability in optimization studies.The solid curve represents the initial analysis of the study while the dashed curve represents the same study when the vari-ability in the ultimate transverse tensile strengthðe ult2Þwas reduced by10%.What this shows is that a variabil-ity reduction of10%in that single property resulted in a 15%reduction in thickness,more importantly weight, for the same probability of failure of10À6.Fig.1.Prepreg laminates.2016W.A.Schulz et al./Composites Science and Technology65(2005)2014–20243.Experimental techniques3.1.Cure Reference Method and Moire´InterferometryResidual and thermal stresses can be determined by using the Cure Reference Method to measure the resid-ual strain in unidirectional or multidirectional compos-ite laminates.CRM uses the full-field laser based optical method of Moire´Interferometry to document strains on the surface of laminates that initiate during the high temperature curing process.The method in-volves replicating a high frequency diffraction grating on the specimen while in the autoclave.The grating acts as a reference to the stress free condition just prior to re-sin solidification.Since the grating is cured with the composite,it carries the same thermal strain and chem-ical shrinkage information as the composite cools.Sub-sequent strains result from two mechanisms,the chemical shrinkage of the polymer matrix and the ther-mal mismatch between the resin and matrix.Strain due to the chemical shrinkage of the epoxy is a one-time event which develops during the curing process,while the thermal mismatch contribution is dependent on the temperature of the specimen,and the cure temperature.The process by which a diffraction grating is pro-duced for application to a composite laminate involves several steps which are outlined in[5].Thefinal stage is production of the autoclave tool that consists of an aluminized grating on a500Â500Â100piece of astrositall Fig.3.Astrositall is an ultra low expansion(ULE)glass with a coefficient of thermal expansion(CTE)of 0.3·10À7mm/mm/°C.The low expansion of the tool is necessary so that the tool does not transfer any ther-mally induced strain to the panel during the transfer process in the autoclave.Most high performance composite laminates are pro-duced with the use of an autoclave.The autoclave is a pressure oven that has vacuum line connections within the pressurized chamber.Once the stacking sequence for the specific laminate is chosen,one can begin to pro-cess the laminate in the following steps:y-up:Assemble the laminate in the specific stackingsequence that has been prescribed.2.Vacuum bagging:Fig.4shows a schematic of the vac-uum bag assembly.The ULE tool with the grating side up is placed at the base of the assembly and the surface is then covered with a non-porous release film.A hole of%1.500diameter is cut into the release film,which allows for the grating to be exposed to the composite surface during the cure cycle.It is crit-ical that thefilm thickness is as minimal as possible so that it will not indent the surface of the composite during the cure process as the resin begins to poly-merize.The prepreg laminate is then placed on top of the releasefilm,centered over the ULE tool,and aligned with the grating.The non-porous releasefilm placed between the tool and the laminate prevents the epoxy from curing to the tool.A layer of porous releasefilm is placed on the upper surface of the lam-inate,which provides two functions,allowing excess resin to be drawn offthe laminate and into the bleeder cloth,as well as for separation from the bleeder cloth.The bleeder cloth is a porous material that absorbs excess resin drawn out of the laminate via vacuum, which allows an appropriatefiber volume fraction to be achieved.The breather cloth,which can be the same material as the bleeder cloth,is used to dis-tribute the vacuum throughout the entire bag.Another layer of non-porous releasefilm is placed between the bleeder and the breather cloths sothatFig.4.Vacuum bagschematic.Fig.3.Astrositall autoclave tool.W.A.Schulz et al./Composites Science and Technology65(2005)2014–20242017excess resin is not transferred into the breather mate-rial resulting in resin being drawn into the vacuum line or clogging the breather cloth which would pre-vent an even vacuum distribution on the laminate during cure.Finally,the ULE and laminate assembly are placed into a vacuum bag;sealed with a sealant tape,and placed in the autoclave for curing.3.Cure preparation:The vacuum bag is connected to thevacuum line.Vacuum is applied and a leak check is performed.It is imperative that the vacuum integrity is maintained,throughout the necessary portions of the curing process,as a poor vacuum can lead to a resin rich laminate.4.Cure:Execute the appropriate cure cycle for theepoxy matrix material.After the composite has cured,the specimen is then ready to be analyzed.A panel with a transferred grating can be seen in Fig.5.The basis of the Cure Reference Method is the tech-nique of Moire´Interferometry.Moire´Interferometry is an optical technique that can be used to determine in-plane displacements.Moire´is characterized by high dis-placement and strain sensitivity,high spatial resolution, and a high signal-to-noise ratio[14].It is a non-contact-ing,full-field method capable of measuring both normal and shear strain.A schematic of the Moire´Interferome-try setup can be seen in Fig.6.The technique is based on the principal of the destructive and constructive interfer-ence of light.The result of the interference is a very char-acteristic pattern of light and dark fringes as seen in Fig.7.These fringe patterns can be used to directly determine the in-plane displacements and residual strains,which lead to residual stresses in each ply.The analysis of the images will be covered in the following section.3.2.Strain gage techniqueOnce strains have been recorded with CRM on each of the panels,they are then sectioned into two pieces. One piece will retain the original grating,while the other will be prepared for strain gage application.The strain gages are applied at room temperature(24°C),and thus room temperature will be our reference point for all strain gage measurements.Vishay Measurements Group WK-13-250BG-350 gages were applied to each specimen with MBond610. These gages and the adhesive were selected for their per-formance ability in the desired temperature range of cryogenic(À190°C)to the cure temperature oftheFig.6.Four beam Moire´interferometerschematic.Fig.5.Cured compositespecimen.Fig.7.Typical fringe patterns(scribed circle is100in diameter). 2018W.A.Schulz et al./Composites Science and Technology65(2005)2014–2024epoxy (182°C).There are a total of four gages applied to each specimen,two of which are on the front of the panel in the corresponding x and y directions (Fig.8),while the other two are on the reverse of the panel in the same location as the gages on the front.The gages were also medium sized gages (0.2500·0.1200).The place-ment of gages on the front and back of the specimens,in addition to the gage size,allows an average of the strain in the x and y directions of the panel to be determined.As strain gages are made of metal alloys,they tend to expand and contract according to changes in tempera-ture.Each alloy type of strain gage is designed to be most accurate over a specific temperature range.Cur-rently no gages exist that are accurate over a broad tem-perature range,such as ours,without implementing temperature compensation.Through our experiments,the measured strain solely due to a gage Õs own expansion at extreme temperatures was as high as 0.2%strain.Gages from the same lot were applied to astrositall and a titanium alloy (Ti6–4Al–4V)which were used as reference materials to compensate for temperature ef-fects.The strain as a function of temperature was known for each of the reference materials.The strain on the ref-erence material was measured at the same time and tem-perature as the gages on the composite specimens.Taking the difference between the measured strain on the reference material and the theoretical strain the material should experience allowed the calculation of the gage expansion.This quantity was then removed from all of the gages on the composite specimens yield-ing the true strain of the specimen at that temperature.The gages were conditioned and read by the use of National Instruments data acquisition hardware and the strains were recorded from the cure temperature of 182°C down to the temperatures of LN 2(À190°C).4.Data analysis 4.1.StrainOnce the fringe patterns on the specimens have been photographed,the resulting strain field images need to be analyzed.As was seen in Fig.7,the resulting images are a pattern of light and dark bands,where each darkband is referred to as a fringe.The fringe order,or num-ber of fringes,(N )is directly related to the displacement of the composite panel.The relationship between the fringe order and the displacement are shown in Eqs.(1)and (2)for the horizontal and vertical displacement fields,respectively:U ¼N xf ;ð1ÞV ¼N yf;ð2Þwhere f is the frequency of the virtual reference grating that is created inside the interferometer,in this case the frequency is 2400lines/mm,and N x and N y are the number of fringes in the vertical and horizontal images.Now that a relationship between displacements and the number of fringes have been established the absolute strains can then be determined by taking the derivative of the displacements as shown in Eqs.(3)and (4):e x ¼o U o x ¼1f o N x o x !ffi1f D N xD x!;ð3Þe y ¼o V o x ¼1f o N y o y !ffi1f D N yD y !;ð4Þwhere D N x and D N y represent the number of fringes that are seen over a given gage length of D x or D y on the respective image.With these measurements,a room temperature refer-ence point of the surface strain on each panel is able to be attained.This room temperature measurement is the keystone to obtaining an accurate relationship of the strain and thermal contraction as a function of temper-ature for the composite specimens.As mentioned previ-ously,strain gages were used to measure the strains over the desired temperature range of cure to cryogenic,and room temperature was chosen as the reference tempera-ture point.Strain measurements were zeroed out at room temperature and then recorded over the entire temperature range.The measured strain was the relative change in strain from the reference point to the specific temperature at which the measurement was taken.Since the reference point was chosen as room temperature,we were then able to superimpose the room temperature measurement from CRM with the strain gage measure-ments.This allowed the generation of the strain as a pure function of temperature in the composite panels.Figs.9–11show the strain as a function of temperature for all the tested panels in each of the different lay-ups.One can see good agreement between test runs,as evi-denced by the overlap of the experimental data.Also evident is the chemical shrinkage contribution to the to-tal strain on the composite.Looking at the strain versus temperature plots,one can see that the strains do not go to zero at the cure temperature.The strain difference that exists at the cure temperature is the chemical shrinkage contribution.Also noteworthy is thattheFig.8.Specimen with strain gages.W.A.Schulz et al./Composites Science and Technology 65(2005)2014–20242019‘‘quasi-isotropic’’lay-up experiences strain values an or-der of magnitude smaller than the other two lay-ups.This is due to the fact that the lay-up is highly con-strained by having plys in many directions.4.2.Coefficient of thermal expansionThe strain as a function of temperature data can then be transformed into a linear coefficient of thermal expansion (CTE)from cure to the testing temperature.Dividing Eqs.(3)and (4)by the change in temperature gives:CTE x ¼e x D T ¼1f ðT test ÀT cure ÞD N xD x!;ð5ÞCTE y ¼e y D T ¼1f ðT test ÀT cure ÞD N yD y !.ð6ÞFig.12shows CTE as a function of temperature in the x and y directions for the three specimens tested.4.3.Residual stressThe residual stress within a ply can be obtained by analyzing the strain state that the ply would be in if the stresses bonding its neighboring plies together were liberated.This liberated strain we define as the residual strain in the composite,and it is calculated based on the same assumptions as Classical Laminate Theory.The most important assumptions of CLT are that plane sec-tions remain plane and the strain at the surface matches the strain at any point in the interior.The residual strain was calculated for each ply orientation as seen in Eq.(7)by taking the difference between a ply Õs unidirectional behavior and its behavior inside a laminate transformed into the material 1–2coordinate systemf e resg k ¼f e uni g À½s k Áf e lam g .ð7ÞFig.12.Coefficient of thermal expansion as a function oftemperature.Fig.9.Unidirectional strain as a f (T).Fig.10.Optimized angle ply strain as a f (T).Fig.11.‘‘Quasi-isotropic’’strain as a f (T ).2020W.A.Schulz et al./Composites Science and Technology 65(2005)2014–2024After the residual strain has been determined,the resid-ual stress can be defined by a constitutive relation Eq.(8)that relates stress to strain through the use of the stiffness matrix of the composite[Q]f r res gk ¼½Qkf e res gk.ð8ÞThe residual stress in the direction transverse to thefibers is shown in Fig.13for the three different ply orientations within the‘‘quasi-isotropic’’lay-up,as well as the opti-mized panel.Note that the‘‘quasi-isotropic’’lay-up has reached the failure strength(dashed horizontal line)of the matrix at LN2(À196°C)temperatures,a full57°C above its intended operating LH2(À253°C)tempera-ture.Stresses of this magnitude-induced micro-cracking within the matrix and ultimately were the root cause of the failure of the X-33fuel tank.Whereas the residual stress in the optimized configuration is only half of the ultimate matrix strength at the extreme cryogenic tem-peratures.It should also be noted,that the residual stres-ses do not return to zero at the cure temperature of the laminate.This is in fact due to the chemical shrinkage contribution to the residual stresses within the compos-ite.Neglecting the chemical contribution would produce the same curves as presented in Fig.13only they would be shifted down by the amount present at the cure tem-perature($17MPa).If this were the case it can be seen that the predicted residual stresses would now fall below the matrix ultimate strength;yielding a false sense of security about the behavior of the laminate.5.Analytical method5.1.PurposePhysical testing of graphite/epoxy material systems is currently a time intensive process.Each combination of fiber and epoxy behaves differently from any other com-bination.Specific combinations are chosen for a partic-ular task that needs to be accomplished.In order to choose the correct material combination,designers need to be able to fully understand the physical behavior of the combination that they chose.Material behavior in-cludes elastic properties such as YoungÕs Modulus in thefiber and transverse directions,Shear Modulus, and PoissonÕs Ratio,as well as thermal expansion behavior.Obtaining these elastic properties is consid-ered a trivial task compared to quantifying properties such as the coefficient of thermal expansion(CTE)in thefiber and transverse directions or the chemical shrinkage imposed on the material due to polymeriza-tion.All of these properties are important in validating a chosen material system as a viable material to use.In order to obtain the behavior of a specific lay-up, one must construct that lay-up and run it through a ser-ies of tests to obtain its CTE and its mechanical behav-ior.An entirely new test must be conducted for each lay-up of interest of a specific material system.This can be a time consuming and expensive process.Thus, there is a need for a method that can predict material behavior and characteristics of any lay-up in a short time and small cost.The analytical method presented here is proposed as a method to predict the process-induced strains on a composite panel based on a few simple tests carried out on unidirectional samples of the given material sys-tem.This means that the process of testing individual lay-ups of a given material system to determine its behavior can be eliminated.The behavior of a laminate with any ply orientation can be predicted with the infor-mation collected from the tests carried out on the unidi-rectional specimens.5.2.Classical Lamination TheoryCLT is a commonly used predictive tool that makes it possible to analyze complex coupling effects that may oc-cur in composite laminates[15].It is able to predict strains,displacements,and curvatures that develop in a laminate as it is mechanically and thermally loaded.The method is derived from several common assumptions, the most basic of which are that plane sections remain plane,and that there is perfect bonding between layers.A program implementing CLT was written in MAT-LAB to calculate the strains in the given laminates as a function of temperature for comparison with our exper-imental results.Inputs such as:•combined material properties of the lamina for the fiber and matrix(E1,E2,G12,m12,a1(T),a2(T));•stacking sequence and ply thickness;•temperature difference from cure;•chemical shrinkage contributions;•loadingconditions.Fig.13.Residual stress as a function of temperature.W.A.Schulz et al./Composites Science and Technology65(2005)2014–20242021。